FDA Inspection 985599 — Baxter Healthcare Corporation
The FDA completed an inspection of Baxter Healthcare Corporation on Oct 3, 2016 in Jayuya, PR. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Oct 3, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jayuya, PR (United States)